It down-regulates anti-apoptotic proteins (Bcl-2, p-Bad, and survivin) while up-regulating pro-apoptotic proteins (Bax, Bad, and PARP), thereby inhibiting melanoma cell proliferation and demonstrating potential for treating skin tumors [127]. This evidence concerns the gene BAD and melanoma.